Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134019) titled 'The Guiding Role of Homologous Recombination Deficiency Gene Detection in the Clinical Decision-making and Treatment of Breast Cancer' on Oct. 10.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Affiliated Hospital of Xi'an Jiaotong University
Condition:
Patients with breast cancer develop homologous recombination deficiency.
Intervention:
HRD positive:N/A
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-01-01
Target Sample Size: HRD positive:75;HRD negative:75;
Countries of Recruitment:
China
To know more, visit https://www.chictr...